Cells in early stages of chromosome condensation are very vulnerable, and many stresses that do not damage DNA induce a transient return to late G2 phase. Such stresses include the drug-induced disassembly of microtubules, which triggers an ATMindependent G2 checkpoint pathway involving a novel ubiquitin ligase.
an adaptation period or when the stress is alleviated. In these examples, the cell cycle is transiently halted near the end of G2 at a point known as 'antephase' (reviewed in [5] ). It is significant that these same agents cannot stop progression into mitosis when applied after the cell has passed a critical juncture, which in vertebrates occurs during late prophase as cyclin B-Cdk1 starts to accumulate in the nucleus [6] .
The stress-induced reversion of chromosome condensation thus occurs before the explosive activation of cyclin B-Cdk1 which commits the cell to mitosis. This implies that the targets of the reversion pathway are upstream from cyclin B-Cdk1 activation, and that the activity of these targets is ultimately required for entry into mitosis. Such targets likely include, in part, other kinases that are involved in preparing the nucleus (cyclin A-Cdk2 [7] or aurora B [8] , for example) and cytoplasm (Plk1 [9,10], for example) for mitosis. Does the delay in antephase progression, induced by various stressful stimuli, result from triggering the DNA damage checkpoint -for example through oxidative stress, which is thought to be the primary source of DNA breaks in mammals [4] ? The current evidence suggest that the answer to this question is no.
A Late G2 Checkpoint Not Involving DNA Damage When microtubules are suddenly disassembled by nocodazole or colcemid in early prophase, many types of cultured cell return to antephase for 2-4 hours before ultimately entering mitosis in the presence of the drug [11] . This transient delay in antephase induces a 'lag' period of several hours during which the mitotic index does not increase after microtubules are disassembled. The presence of this lag reveals that cells already in antephase when the drug was added are also retarded in entering mitosis. This delay is not seen when microtubules are stabilized by taxol, or when actin filaments are depolymerized by cytochalasin D. Interestingly, a similar delay in entering mitosis has been reported after microtubules were disassembled with colcemid, but not nocodazole, in a variety of normal human cell lines, but not those derived from tumors [12] . As this delay occurs in cells lacking ATM (such as the ataxiatelangiectasia homozygote cell line GM3395 [12] ) or p53 (such as U20S cells), and as the delay is not prevented by caffeine treatment [11] , it is not the result of triggering the DNA damage checkpoint pathways.
In the absence of p53, a transcription factor, cells progress through G1 and S phases in the presence of damaged DNA. But the addition of a functional copy of p53 to mutants lacking the protein restores this checkpoint. This relief-of-dependence is a characteristic feature of a checkpoint control [13] . The lag in the mitotic index seen in normal, but not transformed, cells when microtubules are disassembled suggests that conditions -mutants -can be defined in which timely progression into mitosis no longer depends on the integrity of microtubules. What is Chfr and how does it function in the antephase checkpoint? Surprisingly Kang et al. [9] have recently shown that Chfr is a novel ubiquitin ligase which promotes the formation of high molecular weight ubiquitin conjugates in vitro and in vivo. Ubiquitination is a key step in targeting a protein for subsequent destruction by proteolysis. When made in Xenopus extracts, Chfr retards activation of the cyclin B-Cdk1 kinase, and thus entry into mitosis, by preventing the dephosphorylation of tyrosine 15 on Cdk1. It appears to accomplish this task by targeting Plk1 for destruction. In the absence of Plk1, activation of the Cdc25C phosphatase is delayed and the Wee1 kinase is allowed to maintain its inhibitory phosphorylation of Cdk1. As cells lacking Chfr appear to undergo a normal G2/M transition in the absence of drug treatment, and as there is not normally a requirement for ubiquitin-mediated proteolysis during the G2/M transition, Kang et al. [9] conclude that Chfr is required only for a checkpoint pathway that retards entry into mitosis in the presence of mitotic stress.
It now appears that this is

What Does the Chfr Checkpoint Monitor?
Many questions regarding how the pathway works remain to be resolved. Scolnick and Halazonetis [14] suggested that the checkpoint monitors centrosome separation, prolonging G2 (antephase) in the absence of this event. The earlier observation that Plk1 is required for centrosome maturation, which normally occurs near the time the cell becomes committed to mitosis, lends credence to this idea [15] , as do recent findings that centrosomes are required for the G1/S transition [16, 17] . Moreover, even though many cells in culture enter mitosis with non-separated centrosomes, which induces the transient formation of a monopolar spindle, it is possible that these are retarded in progression through antephase. Fortunately, in many cultured cells the separation of centrosomes is frequently completed prior to chromosome condensation [18, 19] . In view of this, the idea that the Chfr-mediated checkpoint monitors centrosome separation can be tested by simply adding nocodazole to γ-tubulin-GFP producing cells entering prophase in the presence of well-separated centrosomes. Another possibility would be to determine whether drugs that specifically inhibit centrosome separation, such as monastrol [20] , prolong G2.
Jha et al. [12] and Rieder and Cole [11] found that the pathway prolonging antephase is not activated by taxol, which stabilizes microtubules (and also inhibits centrosome separation), whereas Scolnick and Halazonetis [14] report that it is. So it remains unclear whether the pathway is triggered by lack of microtubule function, or some other aspect of microtubule activity. Kang et al. [9] conclude that "once mitotic stress is relieved and defects are repaired, the Chfr ligase is inactivated and de novo synthesis of Plk1 drives cells into mitosis". But live cell analyses show that the checkpoint is extremely leaky, and several hours after microtubule disassembly the cells progress into, and become delayed in, mitosis -even in the continued absence of microtubules. So it is possible that Chfr is activated in response to the sudden destruction of microtubules, which may disrupt a number of microtubulemediated events, including the transport, localization and scaffolding of signaling molecules, all of which are likely important in preparing the cell for mitosis. It will be important to assess how early prophase cells respond to nanomolar concentrations of nocodazole and taxol, which disturb microtubule dynamics without changing the amount of tubulin polymer. Finally, it is possible that Chfr activation is part of a general stress response. In this regard, it remains to be determined whether other insults that prolong antephase also trigger the Chfr pathway. Attractive arguments can be made that progression through G2 is also regulated by stress-activated kinase pathways that are triggered in response to a wide range of changes in intra-and intercellular conditions. These pathways, based on the p38 and JNK kinases, also ultimately modulate cyclin B-Cdk1 activity [4] . Whether inhibiting the activity of stress-activated protein kinases modulates the Chfr pathway remains to be determined. Challenges for the future including determining how the Chfr checkpoint pathway is triggered, identifying its additional molecular constituents, and understanding how it interfaces with other stress-induced kinase pathways that delay cellcycle progression. 
